Murat Kalayoglu
CIK: 0002000002
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Cartesian Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Apr 2, 2026RNAC
Cartesian Therapeutics, Inc.
Exercise(M)Indirect758K shares- - Jan 2, 2026RNAC
Cartesian Therapeutics, Inc.
Award(A)Direct2.6K shares- - Jan 2, 2025RNAC
Cartesian Therapeutics, Inc.
Award(A)Direct2.6K shares- - Oct 11, 2024RNAC
Cartesian Therapeutics, Inc.
Exercise(M)Indirect1.5M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 2, 2026 | RNAC Cartesian Therapeutics, Inc. | Exercise(M) | 758,001 | - | $0 | Indirect |
| Jan 2, 2026 | RNAC Cartesian Therapeutics, Inc. | Award(A) | 2,600 | - | $0 | Direct |
| Jan 2, 2025 | RNAC Cartesian Therapeutics, Inc. | Award(A) | 2,600 | - | $0 | Direct |
| Oct 11, 2024 | RNAC Cartesian Therapeutics, Inc. | Exercise(M) | 1,518,373 | - | $0 | Indirect |
1-4 of 4 transactions
About Kalayoglu Murat
Kalayoglu Murat (SEC CIK 0002000002) files insider reports with the SEC as 10% Owner of Cartesian Therapeutics, Inc. (RNAC).
Signal8 holds 4 ownership filings by Kalayoglu Murat, all Form 4s, filed between Oct 15, 2024 and Apr 6, 2026. Those filings report 4 transactions, from Oct 11, 2024 to Apr 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kalayoglu Murat's filings is in WASHINGTON, DC.
Recent filings by Kalayoglu Murat
Other insiders filing for Cartesian Therapeutics, Inc. (RNAC)
- Hoge Elizabeth, 10% Owner
- Singer Michael, Director
- Brunn Carsten, President and CEO
- Miljkovic Milos, Chief Medical Officer
- Davis Blaine, Chief Financial Officer
- DeSilva Nishan M, Director